Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for FLMNF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for FLMNF and 80,000+ other tickers.
See exactly how FLMNF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FLMNF and 80,000+ other tickers.
The Fielmann Group is a stock-listed German family business active in vision care and audiology. As a provider of eyewear, contact lenses, hearing aids and primary eyecare services, it serves its customers through an omnichannel platform comprised of digital sales channels and retail stores worldwide. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services.
Fielmann Group AG (FLMNY) Q4 2025 Earnings Call Transcript
Fielmann Group's multi-year investment cycle and international expansion have pressured margins and dividends, but set up a strong long-term growth opportunity. Recent earnings and management guidance have restored confidence, with margin recovery and dividend growth expected from 2025 onward. Personnel costs in Germany remain a headwind, but Fielmann's scale, pricing power, and operational improvements should drive market share gains.